Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Andrejak

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Therapie|January 1, 1996
[Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy]M Andrejak, B Lafon, G Decocq, et al.
Transplantation|December 1, 1978
Cryoglobulinaemia in renal transplant recipientsM Andrejak, J Bariety, J Bedrossian, et al.
Coeur Et Medecine Interne|October 1, 1978
[Importance of diuretics in the treatment of arterial hypertension]M Andrejak, A Fournier, B Coevoet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1989
Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin eliminationJ D Lalau, M Andrejak, P Morinière, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 16, 1999
[Could angiotensin II type I receptor antagonists have a superior beneficial effect than that of angiotensin II converting enzyme inhibitors with respect to the risk of cerebrovascular accident?]A Fournier, J M Achard, H Mazouz, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremiaR Makdassi, M Andrejak, P Morinière, et al.
American Journal of Hypertension|November 17, 2001
Direct vascular actions of methyclothiazide in remodeled mesenteric arteries from hypertensive patientsB Colas, T Collin, F Safraou, et al.
American Journal of Hypertension|November 24, 1999
Prevention of stroke and cancer: could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors?J M Achard, A Pruna, L A Fernandez, et al.
Pediatric Nephrology (Berlin, Germany)|November 19, 2004
Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney diseaseZ A Massy, C Mazière, S Kamel, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Value of combined intravenous renal arteriography and pyelography in the diagnosis of renovascular hypertensionA Fournier, J P Cecile, A Remond, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Therapie|January 1, 1996
[Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy]M Andrejak, B Lafon, G Decocq, et al.
Transplantation|December 1, 1978
Cryoglobulinaemia in renal transplant recipientsM Andrejak, J Bariety, J Bedrossian, et al.
Coeur Et Medecine Interne|October 1, 1978
[Importance of diuretics in the treatment of arterial hypertension]M Andrejak, A Fournier, B Coevoet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1989
Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin eliminationJ D Lalau, M Andrejak, P Morinière, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 16, 1999
[Could angiotensin II type I receptor antagonists have a superior beneficial effect than that of angiotensin II converting enzyme inhibitors with respect to the risk of cerebrovascular accident?]A Fournier, J M Achard, H Mazouz, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Comparison of propranolol and atenolol in the control of hyperparathyroidism in uremiaR Makdassi, M Andrejak, P Morinière, et al.
American Journal of Hypertension|November 17, 2001
Direct vascular actions of methyclothiazide in remodeled mesenteric arteries from hypertensive patientsB Colas, T Collin, F Safraou, et al.
American Journal of Hypertension|November 24, 1999
Prevention of stroke and cancer: could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors?J M Achard, A Pruna, L A Fernandez, et al.
Pediatric Nephrology (Berlin, Germany)|November 19, 2004
Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney diseaseZ A Massy, C Mazière, S Kamel, et al.
Clinical Science (London, England : 1979)|December 1, 1980
Value of combined intravenous renal arteriography and pyelography in the diagnosis of renovascular hypertensionA Fournier, J P Cecile, A Remond, et al.
Pageof 10